Navigation Links
The development of a somatostatin sst4 receptor-binding assay using the LEADseeker Multimodality Imaging System

14(tyr11) (final concentration 0.313 nM), 62.5 µg of SPA Imaging Bead, 0.313 µg of receptor preparation added together in a 20-µl volume, and 10 µl of 8-µM unlabeled somatostatin-28 (final concentration 2 µM).

5. For DMSO tolerance studies, DMSO was diluted in assay buffer to give final concentrations per well as shown in the results.

6. Plates were sealed and incubated overnight at room temperature (20–25 ºC).

7. Following incubation, plates were imaged on the LEADseeker Multimodality Imaging System for 5 min with quasi-coincident averaging and 3 x 3 binning.

8. For background estimation, bead-only wells (62.5 µg of bead/well, 20 µl), plus assay buffer (20 µl) were included in all experiments. Typically backgrounds exhibited from bead-only wells were less than 10 integrated optical density (IOD) units, and were routinely subtracted from total and NSB values during data analyses.


Results
Kd determination
Saturation binding was carried out with dilutions of (3-[125I] iodotyrosyl11) Somatostatin-14(tyr11) to give a range of concentrations from 0.0 0347–3.00 nM in the assay wells. The saturation curve (Fig 1) was fitted using non-linear regression with the data analysis package GraphPad Prism v4.0. A Kd value of 0.379 nM (95% confidence intervals 0.298–0.460 nM) was estimated directly from the curve.

DMSO tolerance
Dilutions of DMSO were prepared in assay buffer to give a range of concentrations from 0.125 to 32% (v/v) in the assay wells. From the results shown in Figure 2, it can be seen that the assay was tolerant of DMSO up to a final concentration of 2% (v/v). '"/>

Source:


Page: All 1 2 3 4 5

Related biology technology :

1. The development of a CXCR2 chemokine receptorbinding assay using the LEADseeker Multimodality Imaging System
2. The development of a melanocortin MC4 receptor binding assay using the LEADseeker Multimodality Imaging System
3. The development of a melanocortin MC5 receptor binding assay using the LEADseeker Multimodality Imaging System
4. The development of a calcitonin-gene related peptide (CGRP) receptor-binding assay using the LEADseeker Multimodality Imaging System
5. The development of a serotonin 5-HT2C receptor-binding assay using the LEADseeker Multimodality Imaging System
6. Enzyme Immunoassay for Studying Intracellular Levels of cAMP
7. LiquiChip Kits for bead-based cytokine and kinase assays
8. Quality control of antibodies using the 2100 bioanalyzer and the Protein 200 Plus assay
9. High-content screening of GPCR activation with MetaXpress, AcuityXpress and the Transfluor assay system
10. Bio-Plex Cytokine Immunoassays and ELISA: Comparison of Two Methodologies in Testing Samples From Asthmatic and Healthy Children, Rev A
11. Principles of Curve Fitting for Multiplex Sandwich Immunoassays, Rev B
Post Your Comments:
(Date:6/19/2013)... 2013  U.S. Secretary of State John Kerry ... Syngenta  scientist Mary-Dell Chilton , Ph.D., was ... Prize. The prize is the foremost international award recognizing ... quality, quantity or availability of food in the world. ... recognized for "revolutionary biotechnology discoveries that unlocked the key ...
(Date:6/19/2013)... -- Continuing its long history of proven clinical performance in ... Inc. announces the U.S. Food and Drug Administration (FDA) ... assay for use on its Access 2 immunoassay system. ... Coulter,s troponin I test for over 12 years ... to continue providing dependability to laboratories supporting emergency care," ...
(Date:6/19/2013)... , June 19, 2013 /PRNewswire/ ... Bureau presents Innovative Drug Delivery ... Technology Licensing Opportunities for Generic ... There are more ... release drugs approved all over ...
(Date:6/19/2013)... MN (PRWEB) June 19, 2013 Express ... abuse tests, today announced that it has received Class ... market and sell its DrugCheck® NxStep Onsite Drug ... use of the rapid screening device in near-patient settings, ... Drug Screen Cup received Health Canada Class III approval ...
Breaking Biology Technology:Syngenta's Mary-Dell Chilton named 2013 World Food Prize laureate 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 2Beckman Coulter Announces FDA Clearance of New Access AccuTnI+3 Troponin I Assay for the Access 2 Immunoassay System 3Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 2Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 3Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 2Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 3
... CUREXO Technology Corporation, pioneer in medical robotics ... orthopaedic applications, which is focused on marketing its ... be exhibiting at the upcoming American Association of ... Center in Las Vegas, February 25th through the ...
... INDIANAPOLIS, Feb. 23 Heart patients with acute coronary ... a new treatment option to help prevent heart attacks. ... Lilly and Company (NYSE: LLY ) announced ... for EFIENT (R) (pronounced Ef-ee-ent) (prasugrel) ...
... - Misys Learning Suite Adoption Facilitates Best-Of-Breed ... (FTSE: MSY.L), the global application software and services,company, today announces ... Learning Suite to train its expanding workforce as,part of its ... established user of the core banking system Misys Equation, has,elected ...
Cached Biology Technology:CUREXO Technology Corporation Launches Its ROBODOC(R) Surgical System at Upcoming Orthopaedic Conference in Las Vegas 2European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI 2European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI 3European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI 4European Commission Approves EFIENT(R) (prasugrel) for Patients with Acute Coronary Syndrome Undergoing PCI 5Misys Improves Efficiency and Performance at International Bank of Qatar 2
(Date:6/18/2013)... between 5% and 10% of breast and ovarian cancers ... these tumours are attributable to inherited mutations from the ... patients with these mutations, PARP inhibitors, which are currently ... them a new option for personalised cancer treatment, an ... that a fraction of these patients generate resistance to ...
(Date:6/18/2013)... (18 June 2013). A team of internationally recognized feline ... Sarah Ellis from the University of Lincoln, U.K. and ... U.S.A. were invited by the International Society of Feline ... (AAFP) to compile guidelines for veterinarians, owners and those ... needs of the domestic cat. The new guidelines appear ...
(Date:6/17/2013)... the U.S. exposed to high levels of air pollution while ... child with autism as women who lived in areas with ... of Public Health (HSPH). It is the first large national ... the U.S. , "Our findings raise concerns since, depending on ... study lived in areas where risk of autism was elevated," ...
Breaking Biology News(10 mins):An article in 'Cell' reveals a new resistance mechanism to chemotherapy in breast and ovarian cancer 2Feline behavior experts release guidelines to improve the welfare of cats 2Exposure to high pollution levels during pregnancy may increase risk of having child with autism 2
... -- A project by three Bowling Green State University biologists ... of information that will be usable for years to come ... greenhouse gases and lake ecosystems. Drs. George Bullerjahn, Michael ... "dead zones" in Lake Erie was one of only 41 ...
... premier authorities on aging will share the most up-to-date news ... Older Americans Act, and other current topics at The ... Meeting . This event the largest interdisciplinary conference in ... 18 to 22 in Boston. GSA extends complimentary registration ...
... 11, 2011 in the Jim Wise Theatre on the New ... simulcast broadcast available to viewers worldwide. The independently organized ... and will feature young people in the technology field. ... their passion for innovation and entrepreneurship. "The ...
Cached Biology News:BGSU researchers harness power of genome institute for Great Lakes study 2BGSU researchers harness power of genome institute for Great Lakes study 3Register now! Boston meeting will showcase latest aging discoveries 2Register now! Boston meeting will showcase latest aging discoveries 3Live from Newark: TEDxNJIT simulcast on Nov. 11 to viewers worldwide 2
Homo sapiens inhibin, beta B (activin AB beta polypeptide) Antigen: Recombinant Protein(142~254aa)...
Wheat Germ Agglutinin (WGA) PS SPA Imaging Bead, 2 g. Category: Leadseeker Beads....
... 8 micro-bore tubes to 1 outflow Single-cell ... Rapid (several millisecond) solution change Very ... , Solid construction 360, 250 and ... For mounting on any micromanipulator Available in ...
Sf21 cells derived from Spodoptera frugiperda ovarian cells are recommended for high-level production of recombinant proteins. Higher expression levels of some proteins are seen due to the larger ce...
Biology Products: